Dr. Arthur E. Okere, MD

Dr. Okere practices at Cardiovascular Associates of the Delaware Valley,P A in Brick, New Jersey.

Dr. Okere's NPI, 1790928612, was assigned on April 7, 2009. Dr. Okere graduated from Boston University School of Medicine in 2007. Dr. Okere holds New Jersey license 25MA09707400.

Dr. Okere's primary practice is Cardiovascular Associates of the Delaware Valley,P A, at 35 Beaverson Blvd, Brick, NJ 08723 in Ocean County. The practice phone is (856) 547-0539.

Dr. Okere's primary practice is Cardiovascular Associates of the Delaware Valley,P A in Brick, New Jersey. Dr. Okere is also affiliated with Ocean University Medical Center. The medical group on file is Cardiovascular Associates of The Delaware Valley (The Heart House). Dmand AI also links Dr. Okere to 4 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Okere practices, 8 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Okere's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Okere's licenses on file in 2 states: New Jersey and New York.

CMS data shows 5,871 Medicare services from Dr. Okere across 34 procedure codes in 2024, for 1,255 Medicare patients. Medicare paid $831,813 for them.

CMS counts 1,255 Medicare patients who saw Dr. Okere in 2024. The largest group is 65 to 74, with 478 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Okere's median patient age at 68, with 50% women.

In 2024, Dr. Okere wrote 3,443 Medicare Part D claims for 545 patients. 77% of them were for generic drugs. CMS names the drug for 3,136 of them, across 41 drugs with 11 or more claims each, at $922,993 in total drug cost. In 2023, CMS named 2,623 claims across 40 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Okere for performance year 2024, reported as part of a group. Dr. Okere accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 34 procedures of coronary angioplasty and stenting by Dr. Okere, more than 71% of the clinicians it reports for that procedure.

Dmand AI links 16 papers to Dr. Okere, published from 2021 to 2025. 2022 was the busiest year, with 7. Dr. Okere has published most often in Cureus. Dr. Okere's most frequent co-authors are Sharon Hechter, MD, Mina Aknouk, MD and Desai Victor Jiang, MD.

CMS Open Payments shows 769 general payments to Dr. Okere from 43 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbott Laboratories paid the most, $3,893.

Dr. Okere graduated from Boston University School of Medicine in 2007.